Table 1.

Characteristics of the cohort of patients

	Total sample		Health care proxy						Advance directives
			Yes		No		N/A		Yes		No		N/A
	n.	%	n.	%	n.	%	n.	%	n.	%	n.	%	n.	%
Year medical records were studied
2008-2009	60	30.5	35	58.3	14	23.3	11	18.3	3	5.0	34	56.7	23	38.3
2010	54	27.4	38	70.4	10	18.5	6	11.1	4	7.4	34	63.0	16	29.6
2011-2012	83	42.1	54	65.1	14	16.9	15	18.1	5	6.0	52	62.7	26	31.3
Population	197	100.0	127	64.5	38	19.3	32	16.2	12	6.1	120	60.9	65	33.0
Gender
Male	110	55.8	71	64.5	21	19.1	18	16.4	6	5.5	72	65.5	32	29.1
Female	87	44.2	56	64.4	17	19.5	14	16.1	6	6.9	48	55.2	33	37.9
Sex ratio	1.26		1.27						1
Age groups on diagnosis
<70	124	63.0	79	63.7	27	21.8	18	14.5	5	4.0	83	66.9	36	29.0
≥70	73	37.0	48	65.8	11	15.1	14	19.2	7	9.6	37	50.7	29	39.7
Median age (years)	66		67						73
Average age (years) SD (min-max)	64.4 ± 15.8 [18;91]		64.8 ± 14.2 [23;91]						72.5 ± 5.6 [62;83]
Marital status
Married or with a partner	138	70.1	98	71.0	24	17.4	16	11.6	9	6.5	87	63.0	42	30.4
Single/Widowed	44	22.3	19	43.2	11	25.0	14	31.8	3	6.8	22	50.0	19	43.2
Not filled in	15	7.6	10	66.7	3	20.0	2	13.3	-	-	11	73.3	4	26.7
Pathologies
Lymphoid pathologies1	136	69.0	91	66.9	26	19.1	19	14.0	4	2.9	81	59.6	51	37.5
Myeloid pathologies and others2	61	31.0	36	59.0	12	19.7	13	21.3	8	13.1	39	63.9	14	23.0
Wish to meet a religious representative
	16	8.1	12	75.0	1	6.3	3	18.8	6	37.5	9	56.3	1	6.3
Wish to meet a volunteer
	9	4.6	6	66.7	1	11.1	2	22.2	3	33.3	5	55.6	1	11.1

¹Lymphoid pathologies: NHL, Hodgkin’s disease, Hairy cell leukaemia, myeloma, amyloidosis, Waldenstrom’s disease, CLL).

²Myeloid pathologies and others: acute leukaemia and myelodysplasia (RAEB), CMML, myeloproliferative disorders (CML, primary myelofibrosis, essential thrombocythemia, polycythemia vera, rare non malignant haemopathies (aplastic anemia, severe autoimmune cytopenias, thrombotic microangiopathies, immune deficiencies.